- Genetic Material
- Genetic Testing
Animal Genetics Market size is valued at USD 7,531.8 million in 2021 and is expected to reach a value of USD 10,668.9 million by 2028, growing at a CAGR of 5.1% during the forecast period 2022 to 2028. The global market provides a detailed overview of the animal genetics market and that can be segmented by live animal, material and service. By live animal, the animal genetics market has been segmented into porcine, bovine, poultry, canine, and others. The porcine segment is likely to be the largest and fastest-growing segment in terms of live animals. Based on material, the animal genetics market is segmented into embryos and semen. Among these, the embryo segment is expected to have the fastest-growing market during the forecast period 2022-2028. On the basis of service, the market is segregated into genetic trait tests, genetic diseases tests and DNA typing. The genetic trait test segment held a considerable market share during the forecast period.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Few key factors fueling the market growth include rising approval of progressive genetic practices, growing preference for animal protein and adoption of various genetic services, acceptance of advanced genetic technologies, and rising consumption of dairy products and animal-derived protein. Also, the growing need for specialized breeding programs for breeds with poor economic performance is another factor responsible for market growth.
The animal genetics market is projected to expand at a CAGR of 5.1% during the forecast period
Biopolymer GmbH & Co KG (Germany), Merz GmbH & Co. KGaA (Germany), Lumenis (U.S.), Revance Therapeutics, Inc. (U.S), Speciality European Pharma (U.K.), Mentor Worldwide LLC (U.K.), Anika Therapeutics, Inc., Contura International A/S (Denmark), Cynosure, Inc. (U.S.), Fibrocell Science Inc. (U.S), Galderma S/A (Switzerland).
Asia Pacific is the fastest-growing region for animal genetics market
[urltag url='request-table-of-content']